StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –

Novartis Scemblix Global Growth in USD by Quarter

Scemblix Global Growth in USD (% USD) (%)

QuarterlyAnnual

Novartis Scemblix Global Growth in USD: 66.0% in Q3 2026, down 31.0 pts from a year earlier.

Latest, Q3 2026
66.0%
Period ended Sep 30, 2026
Change on a year earlier
-31.0 pts
97.0% in Q3 2025
History
15 quarters
Since Q1 2023
Sources
15
Documents cited below

Where the Q3 2026 figure comes from

“|| Scemblix | 593 | 358 | 66 | 67”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedScemblix Global Growth in USD (% USD) (%)Year on yearSource
Q3 2026Sep 30, 202666.0%-31.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202689.0%+7.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202682.0%+7.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202589.0%+23.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202597.0%+25.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202582.0%+27.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202575.0%-4.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202466.0%-74.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202472.0%-87.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202455.0%-187.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202479.0%-125.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 2023140.0%–Novartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 2023159.0%–Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 2023242.0%–Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 2023204.0%–Novartis Form 6-K (0001370368-23-000046) ↗

Cite this data

StockData. (2026). Novartis Scemblix Global Growth in USD (%), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-scemblix-yoy-usd-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.